Novavax (NVAX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	119.95M
Short-term investments available-for-sale
Accounts receivables	591K
Unbilled receivables
Prepaid expenses and other current assets	21.51M
Total current assets	353.91M
Property and equipment, net	40.96M
Goodwill	52.69M
Other non-current assets	410K
Total assets	459.63M
Accounts payable	16.23M
Accrued expenses and other current liabilities	26.1M
Current portion of notes payable	45K
Deferred revenue	30.16M
Deferred rent	1.07M
Total current liabilities	75.68M
Warrant liability
Non-current portion of notes payable
Deferred rent	12.24M
Total liabilities	409.84M
Commitments and contingences	0
Preferred stock, $0.01 par value, 2,000,000 shares authorized; no shares issued and outstanding	0
Common stock, $0.01 par value, 200,000,000 shares authorized; and 115,125,113 shares issued and 114,669,683 shares outstanding at June 30, 2011 and 111,492,014 shares issued and 111,036,584 shares outstanding at December 31, 2010	2.72M
Additional paid-in capital	932.21M
Notes receivable from former directors
Accumulated deficit	-872.89M
Treasury stock, 455,430 shares, cost basis	-2.45M
Accumulated other comprehensive income	-9.8M
Total stockholders' equity	49.78M
Total liabilities and stockholders' equity	459.63M

Entities mentioned with NVAX

View All Entities